col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

American Society of Hematology: Blood Advances
  original article Date Title Authors   All Authors
1 [GO] 2022―Jan―10 Upregulation of cAMP prevents antibody-mediated thrombus formation in COVID-19 Jan Zlamal, Karina Althaus, Hisham Jaffal, Helene Häberle, Lisann Pelzl, Anurag Singh, et al. (+10)
2 [GO] 2022―Jan―10 Successful outcome of pre-engraftment COVID-19 in an HCT patient: impact of targeted therapies and cellular immunity Hoda Pourhassan, CORINNA LA ROSA, Flavia Chiuppesi, Alfredo Puing, Ibrahim Aldoss, Yoonsuh Park, et al. (+12)
3 [GO] 2022―Jan―10 SARS-CoV-2-specific T-cell responses to recurrent COVID-19 pneumonitis in a patient with post-CART B cell aplasia Angus Hodder, Lindsey Williams, Jan Chu, Alasdair Bamford, Charlene Rodrigues, Kimberley C Gilmour, et al. (+5)
4 [GO] 2022―Jan―06 Inflammasome activation in neutrophils of patients with severe COVID-19 Karen Aymonnier, Julie Ng, Laura E Fredenburgh, Katherin Zambrano-Vera, Patrick Münzer, Sarah Gutch, et al. (+8)
5 [GO] 2021―Dec―24 COVID-19 vaccination in patients with immune thrombocytopenia Chantal Visser, Maurice Swinkels, Erik van Werkhoven, F. Nanne Nanne Croles, Heike Susanne Noordzij-Nooteboom, Matthijs Eefting, et al. (+12)
6 [GO] 2021―Dec―23 Impaired Immune Response to COVID-19 Vaccination in Patients with B-Cell Malignancies after CD19 CART Cell Therapy Saurabh Dahiya, Tim Luetkens, Forat Lutfi, Stephanie V. Avila, Thierry Iraguha, Philip J Margiotta, et al. (+10)
7 [GO] 2021―Dec―15 SARS-CoV-2 neutralizing antibody treatment in COVID-19 patients with immunodeficiency due to B-cell non-Hodgkin lymphoma Jakob J Malin, Veronica Di Cristanziano, Carola Horn, Elisabeth Pracht, Jorge Garcia Borrega, Eva Heger, et al. (+10)
8 [GO] 2021―Dec―14 Booster effect after SARS-CoV-2 vaccination in hematological immunocompromised patients with prior COVID-19 Jose Luis L Piñana, Ramon Garcia-Sanz, RODRIGO MARTINO, Maria Garcia-Roa, Gabriel-Andres Martin-Martin, Irene Risco-Galvez, et al. (+11)
9 [GO] 2021―Dec―06 Cellular and humoral Immune response to mRNA COVID-19 vaccination in subjects with chronic lymphocytic leukemia Zoe Lyski, Myung S Kim, David Xthona Lee, Hans-Peter Raué , Vikram Raghunathan, Janet Griffin, et al. (+6)
10 [GO] 2021―Dec―03 Altered fibrin clot structure and dysregulated fibrinolysis contribute to thrombosis risk in severe COVID-19 Malgorzata Wygrecka, Anna Birnhuber, Benjamin Seeliger, Laura Michalick, Oleg Pak, Astrid-Solveig Schultz, et al. (+19)
11 [GO] 2021―Dec―01 C5a and C5aR1 are key drivers of microvascular platelet aggregation in clinical entities spanning from aHUS to COVID-19 Sistiana Aiello, Sara Gastoldi, Miriam Galbusera, Piero Luigi Ruggenenti, Valentina Portalupi, Stefano Rota, et al. (+9)
12 [GO] 2021―Dec―01 Immunogenicity of COVID-19 vaccines in patients with hematological malignancy: a systematic review and meta-analysis Joanne S.K. Teh, Julien Coussement, Zoe C.F. Neoh, Tim Spelman, Smaro Lazarakis, Monica A Slavin, Benjamin W Teh
13 [GO] 2021―Nov―29 Cellular and humoral immunogenicity of the mRNA-1273 SARS-CoV-2 vaccine in patients with hematologic malignancies Moraima Jiménez, Elisa Roldan, Candela Fernández- Naval, Guillermo Villacampa, Monica Martinez-Gallo, Daniel Medina-Gil, et al. (+23)
14 [GO] 2021―Nov―08 COVID-19 and CAR-T cells: current challenges and future directions-a report from the EPICOVIDEHA survey by EHA-IDWP Alessandro Busca, Jon Salmanton-García, Paolo Corradini, Francesco Marchesi, Alba Cabirta, Roberta Di Blasi, et al. (+23)
15 [GO] 2021―Nov―02 American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on post-discharge thromboprophylaxis Adam Cuker, Eric K. Tseng, Robby Nieuwlaat, Pantep Angchaisuksiri, Clifton Blair, Kathryn Dane, et al. (+47)
16 [GO] 2021―Nov―01 SARS-CoV-2 spike-dependent platelet activation in COVID-19 vaccine-induced thrombocytopenia Jacob Appelbaum, Donald M. Arnold, John G. Kelton, Terry B Gernsheimer, Stefan D Jevtic, Nikola Ivetic, et al. (+2)
17 [GO] 2021―Oct―18 A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study Carlo Visco, Luigi Marcheselli, Roberto Mina, Marianna Sassone, Anna Guidetti, Domenico Penna, et al. (+51)
18 [GO] 2021―Oct―06 Six Months Antibody Persistence after BNT162b2 mRNA COVID-19 Vaccination in Patients with Chronic Lymphocytic Leukemia Yair Herishanu, Irit Avivi, Shai Levi, Gabi Shefer, Yotam Bronstein, Miguel Morales Moshiashvili, et al. (+4)
19 [GO] 2021―Sep―28 Impact of sickle cell trait on morbidity and mortality from SARS-CoV-2 infection Lauren E. Merz, Kavita Mistry, Donna Neuberg, Revital Freedman, Gerda Menard, David M. Dorfman, et al. (+3)
20 [GO] 2021―Sep―20 Heparin-induced Thrombocytopenia in Patients with Coronavirus Disease 2019: Systematic Review and Meta-analysis Noppacharn Uaprasert, Nuanrat Tangcheewinsirikul, Ponlapat Rojnuckarin, Rushad Patell, Jeffrey I. Zwicker, Thita Chiasakul
21 [GO] 2021―Sep―16 Poor neutralizing antibody responses in 106 patients with WM after vaccination against SARS-CoV-2; a prospective study Maria Gavriatopoulou, Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, Alexandros Briasoulis, Sentiljana Gumeni, Panagiotis Malandrakis, et al. (+8)
22 [GO] 2021―Sep―02 American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate intensity anticoagulation in critically ill patients Adam Cuker, Eric K. Tseng, Robby Nieuwlaat, Pantep Angchaisuksiri, Clifton Blair, Kathryn Dane, et al. (+41)
23 [GO] 2021―Aug―13 Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with B-cell non-Hodgkin lymphoma C. Perry, E. Luttwak, R. Balaban, G. Shefer, M. M. Morales, A. Aharon, et al. (+10)
24 [GO] 2021―Aug―13 Activity of mRNA COVID-19 vaccines in patients with lymphoid malignancies Jennifer L. Crombie, Amy C. Sherman, Chi-An Cheng, Christine E. Ryan, Rebecca Zon, Michaël Desjardins, et al. (+13)
25 [GO] 2021―Jul―13 Autoimmune- and complement-mediated hematologic condition recrudescence following SARS-CoV-2 vaccination Andrew Jay Portuguese, Cassandra Sunga, Rebecca Kruse-Jarres, Terry Gernsheimer, Janis Abkowitz
26 [GO] 2021―Jul―01 Comorbidities are risk factors for hospitalization and serious COVID-19 illness in children and adults with sickle cell disease Lana Mucalo, Amanda M. Brandow, Mahua Dasgupta, Sadie F. Mason, Pippa M. Simpson, Ashima Singh, et al. (+4)
27 [GO] 2021―Jun―17 A case of thrombocytopenia and multiple thromboses after vaccination with ChAdOx1 nCoV-19 against SARS-CoV-2 Anne Louise Tølbøll Sørensen, Magalie Rolland, Jacob Hartmann, Zitta Barrella Harboe, Casper Roed, Tomas Ø. Jensen, et al. (+13)
28 [GO] 2021―Apr―01 COVID-19 in individuals with sickle cell disease/trait compared with other Black individuals Ashima Singh, Amanda M. Brandow, Julie A. Panepinto
29 [GO] 2021―Apr―01 Risk factors for seasonal human coronavirus lower respiratory tract infection after hematopoietic cell transplantation Chikara Ogimi, Hu Xie, Alpana Waghmare, Masumi Ueda Oshima, Kanwaldeep K. Mallhi, Keith R. Jerome, et al. (+3)
30 [GO] 2021―Mar―08 Heterogeneous NLRP3 inflammasome signature in circulating myeloid cells as a biomarker of COVID-19 severity Johan Courjon, Océane Dufies, Alexandre Robert, Laurent Bailly, Cédric Torre, David Chirio, et al. (+17)
31 [GO] 2021―Mar―03 The SARS-CoV-2 receptor-binding domain preferentially recognizes blood group A Shang-Chuen Wu, Connie M. Arthur, Jianmei Wang, Hans Verkerke, Cassandra D. Josephson, Daniel Kalman, et al. (+3)
32 [GO] 2021―Feb―26 A neutrophil activation signature predicts critical illness and mortality in COVID-19 Matthew L. Meizlish, Alexander B. Pine, Jason D. Bishai, George Goshua, Emily R. Nadelmann, Michael Simonov, et al. (+24)
33 [GO] 2021―Feb―10 Kinase inhibitors developed for treatment of hematologic malignancies: implications for immune modulation in COVID-19 Chaja F. Jacobs, Eric Eldering, Arnon P. Kater
34 [GO] 2021―Feb―09 American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19 Adam Cuker, Eric K. Tseng, Robby Nieuwlaat, Pantep Angchaisuksiri, Clifton Blair, Kathryn Dane, et al. (+39)
35 [GO] 2021―Feb―09 COVID-19 and hematopoietic stem cell transplantation and immune effector cell therapy: a US cancer center experience Katie Maurer, Anna Saucier, Haesook T. Kim, Utkarsh Acharya, Clifton C. Mo, Julie Porter, et al. (+11)
36 [GO] 2021―Feb―06 Sustained prothrombotic changes in COVID-19 patients 4 months after hospital discharge Fien A. von Meijenfeldt, Sebastian Havervall, Jelle Adelmeijer, Annika Lundström, Maria Magnusson, Nigel Mackman, et al. (+2)
37 [GO] 2021―Feb―02 Dynamic angiopoietin-2 assessment predicts survival and chronic course in hospitalized patients with COVID-19 Erica Villa, Rosina Critelli, Simone Lasagni, Alessandra Melegari, Angela Curatolo, Ciro Celsa, et al. (+28)
38 [GO] 2021―Jan―29 Dissemination of extreme levels of extracellular vesicles: tissue factor activity in patients with severe COVID-19 Christophe Guervilly, Amandine Bonifay, Stephane Burtey, Florence Sabatier, Raphaël Cauchois, Evelyne Abdili, et al. (+10)
39 [GO] 2021―Jan―29 Platelet reactivity to thrombin differs between patients with COVID-19 and those with ARDS unrelated to COVID-19 Younes Zaid, Fadila Guessous, Florian Puhm, Wail Elhamdani, Lamyae Chentoufi, Andrew Conway Morris, et al. (+4)
40 [GO] 2021―Jan―13 Clinical predictors of poor outcomes in patients with sickle cell disease and COVID-19 infection Caterina P. Minniti, Ahmar U. Zaidi, Mehdi Nouraie, Deepa Manwani, Gary D. Crouch, Andrew S. Crouch, et al. (+8)
41 [GO] 2020―Dec―18 A toolkit for the collection of thrombosis-related data elements in COVID-19 clinical studies Deborah M. Siegal, Geoffrey D. Barnes, Nicole J. Langlois, Adrienne Lee, Saskia Middeldorp, Leslie Skeith, et al. (+2)
42 [GO] 2020―Dec―17 Incidence of symptomatic, image-confirmed venous thromboembolism following hospitalization for COVID-19 with 90-day follow-up Richard Salisbury, Valentina Iotchkova, Sarah Jaafar, Joshua Morton, Gavinda Sangha, Akshay Shah, et al. (+3)
43 [GO] 2020―Dec―09 Evidence of thrombotic microangiopathy in children with SARS-CoV-2 across the spectrum of clinical presentations Caroline Diorio, Kevin O. McNerney, Michele Lambert, Michele Paessler, Elizabeth M. Anderson, Sarah E. Henrickson, et al. (+22)
44 [GO] 2020―Dec―05 Outcomes of patients with hematologic malignancies and COVID-19: a report from the ASH Research Collaborative Data Hub William A. Wood, Donna S. Neuberg, J. Colton Thompson, Martin S. Tallman, Mikkael A. Sekeres, Laurie H. Sehn, et al. (+8)
45 [GO] 2020―Dec―05 Challenges in treatment of patients with acute leukemia and COVID-19: a series of 12 patients Susanne Ghandili, Susanne Pfefferle, Kevin Roedl, Piet Sonnemann, Panagiotis Karagiannis, Olaf Boenisch, et al. (+11)
46 [GO] 2020―Nov―02 Frequency of venous thromboembolism in 6513 patients with COVID-19: a retrospective study Jason B. Hill, David Garcia, Mark Crowther, Bryan Savage, Shira Peress, Kevin Chang, Steven Deitelzweig
47 [GO] 2020―Oct―19 Impaired natural killer cell counts and cytolytic activity in patients with severe COVID-19 Mohammed Osman, Rehan M. Faridi, Wendy Sligl, Meer-Taher Shabani-Rad, Poonam Dharmani-Khan, Arabesque Parker, et al. (+5)
48 [GO] 2020―Oct―14 The association of ABO blood group with indices of disease severity and multiorgan dysfunction in COVID-19 Ryan L. Hoiland, Nicholas A. Fergusson, Anish R. Mitra, Donald E. G. Griesdale, Dana V. Devine, Sophie Stukas, et al. (+8)
49 [GO] 2020―Oct―14 Reduced prevalence of SARS-CoV-2 infection in ABO blood group O Mike Bogetofte Barnkob, Anton Pottegård, Henrik Støvring, Thure Mors Haunstrup, Keld Homburg, Rune Larsen, et al. (+5)
50 [GO] 2020―Oct―08 Successful transfer of anti-SARS-CoV-2 immunity using convalescent plasma in an MM patient with hypogammaglobulinemia and COVID-19 Tim Luetkens, Ryan Metcalf, Vicente Planelles, Yue Zheng, Erin T. Larragoite, Emily S. Spivak, et al. (+11)
51 [GO] 2020―Sep―14 Successful management of SARS-CoV-2 acute respiratory distress syndrome and newly diagnosed acute lymphoblastic leukemia Lia Phillips, Jovana Pavisic, Dominder Kaur, N. Valerio Dorrello, Larisa Broglie, Nobuko Hijiya
52 [GO] 2020―Sep―11 COVID-19 convalescent plasma clears SARS-CoV-2 refractory to remdesivir in an infant with congenital heart disease Zahidee Rodriguez, Andi L. Shane, Hans Verkerke, Christopher Lough, Matthew G. Zimmerman, Mehul Suthar, et al. (+8)
53 [GO] 2020―Sep―04 Variable CD34+ recovery of cryopreserved allogeneic HPC products: transplant implications during the COVID-19 pandemic Duncan Purtill, Vicki Antonenas, Paul Chiappini, Daochen Tong, Elizabeth O’Flaherty, Ashish Bajel, et al. (+11)
54 [GO] 2020―Aug―25 The management of venous thromboembolism in hospitalized patients with COVID-19 Alex C. Spyropoulos
55 [GO] 2020―Jul―01 Ensuring continuity of care of hematologic patients during COVID-19 pandemic in a tertiary hospital in Lombardy (Italy) Bruno Fattizzo, Juri Alessandro Giannotta, Wilma Barcellini, Maria Chiara Barbanti, Cristina Bucelli, Ramona Cassin, et al. (+25)
56 [GO] 2020―Jun―23 COVID-19 coagulopathy vs disseminated intravascular coagulation Marcel Levi
57 [GO] 2020―Jun―19 A report of clustered COVID-19 in a hematology ward Yaohui Wu, Fang Liu, Yun Fang, Xuan Lu, Yingying Wu, Linghui Xia, Mei Hong
58 [GO] 2020―Apr―03 First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab Xuhan Zhang, Kaidi Song, Fei Tong, Mingming Fei, Hui Guo, Zhaohui Lu, et al. (+2)


[de][en]

Last change 2022―Jan―20 20:43:25 UTC

© Daten-Quadrat 2022       Done in 0.006 sec